Noninvasive Monitoring Glutathione Metabolism in Tumors

无创监测肿瘤中的谷胱甘肽代谢

基本信息

项目摘要

Glutathione is a ubiquitous tripeptide found in high concentration in normal tissue and is frequently elevated in tumors. Glutathione and its oxidized disulfide form the primary reduction/oxidation (redox) buffer in the cell. The cellular redox balance controls gene expression, differentiation, proliferation and apoptosis. In normal tissue, glutathione protects the cell from environmental stress and the cancer cell has adapted this defense mechanism to shield tumor cells from the effects of therapy. In cell culture, our laboratory has shown that glutathione metabolism is consistently increased in drug-resistant cancers. These findings are supported by a number of clinical studies relating glutathione metabolism to patient survival. However the clinical studies rely upon invasive repeated sampling of the tumor tissue since methods to monitor glutathione metabolism in intact rumors are lacking. Over the past two years, as part of an NTH-funded pilot project, we succeeded in developing a magnetic resonance method combined with stable isotope infusion to monitor glutathione metabolism in vivo. This proposal builds upon the feasibility established in the pilot project and plans to Use these methods to monitor glutathione metabolism non-invasively in R3230 mammary, 9L glioma and FSA fibrosarcoma tumors and drug-resistant variants in rats. Glutathione metabolism will be assessed in relation to tumor growth rate, vascularization and expression of key enzymes involved in redox metabolism. Since a drop in intracellular glutathione levels is one of the earliest events in apoptosis, therapy-induced changes in glutathione metabolism detected by magnetic resonance will be an early indicator of tumor response. Since altered redox balance appears to be a universal characteristic of proliferating cells in general and cancer in particular, methods to non-invasively monitor redox metabolism offers new insight into a process critical to planning and evaluating cancer therapy.
谷胱甘肽是一种普遍存在的三肽,在正常组织中浓度很高,并且在正常组织中经常升高。 肿瘤。谷胱甘肽及其氧化二硫化物形成细胞中的主要还原/氧化(氧化还原)缓冲液。 细胞氧化还原平衡控制基因表达、分化、增殖和凋亡。正常情况下 在组织中,谷胱甘肽保护细胞免受环境压力,而癌细胞已经适应了这种防御 保护肿瘤细胞免受治疗影响的机制。在细胞培养中,我们的实验室表明 在耐药癌症中,谷胱甘肽代谢持续增加。这些发现得到了以下证据的支持 许多有关谷胱甘肽代谢与患者生存的临床研究。然而临床研究依赖 自从监测完整的谷胱甘肽代谢的方法以来,对肿瘤组织进行侵入性重复取样 缺乏谣言。在过去的两年里,作为 NTH 资助的试点项目的一部分,我们成功地 开发磁共振方法结合稳定同位素输注来监测谷胱甘肽 体内代谢。该提案建立在试点项目中建立的可行性之上,并计划使用 这些方法可无创监测 R3230 乳腺、9L 神经胶质瘤和 FSA 中的谷胱甘肽代谢 大鼠纤维肉瘤肿瘤和耐药变异。谷胱甘肽代谢将根据以下方面进行评估 肿瘤生长速率、血管化和参与氧化还原代谢的关键酶的表达。自从一个 细胞内谷胱甘肽水平下降是细胞凋亡中最早的事件之一,治疗引起的细胞凋亡变化 磁共振检测到的谷胱甘肽代谢将成为肿瘤反应的早期指标。自从 氧化还原平衡的改变似乎是增殖细胞和癌症的普遍特征 特别是,非侵入性监测氧化还原代谢的方法为对氧化还原代谢至关重要的过程提供了新的见解。 规划和评估癌症治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MICHAEL GAMCSIK其他文献

MICHAEL GAMCSIK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MICHAEL GAMCSIK', 18)}}的其他基金

Mapping Functional Heterogeneity in Tissue
绘制组织中的功能异质性
  • 批准号:
    10018055
  • 财政年份:
    2019
  • 资助金额:
    $ 26.01万
  • 项目类别:
Mapping Functional Heterogeneity in Tissue
绘制组织中的功能异质性
  • 批准号:
    9806947
  • 财政年份:
    2019
  • 资助金额:
    $ 26.01万
  • 项目类别:
High-Throughput Screening Under Static or Dynamic Hypoxia
静态或动态缺氧下的高通量筛选
  • 批准号:
    9315116
  • 财政年份:
    2016
  • 资助金额:
    $ 26.01万
  • 项目类别:
PDAC-on-a-Chip for Selection of Aggressive, Therapy-Resistant Tumor Cells
用于选择侵袭性、治疗耐药性肿瘤细胞的 PDAC 芯片
  • 批准号:
    8384934
  • 财政年份:
    2012
  • 资助金额:
    $ 26.01万
  • 项目类别:
PDAC-on-a-Chip for Selection of Aggressive, Therapy-Resistant Tumor Cells
用于选择侵袭性、治疗耐药性肿瘤细胞的 PDAC 芯片
  • 批准号:
    8518272
  • 财政年份:
    2012
  • 资助金额:
    $ 26.01万
  • 项目类别:
Spectroscopic Imaging of Antioxidant Metabolism in the Brain
大脑中抗氧化剂代谢的光谱成像
  • 批准号:
    7236870
  • 财政年份:
    2007
  • 资助金额:
    $ 26.01万
  • 项目类别:
Spectroscopic Imaging of Antioxidant Metabolism in the Brain
大脑中抗氧化剂代谢的光谱成像
  • 批准号:
    7489932
  • 财政年份:
    2007
  • 资助金额:
    $ 26.01万
  • 项目类别:
Noninvasive Monitoring Glutathione Metabolism in Tumors
无创监测肿瘤中的谷胱甘肽代谢
  • 批准号:
    7209039
  • 财政年份:
    2006
  • 资助金额:
    $ 26.01万
  • 项目类别:
Noninvasive Monitoring Glutathione Metabolism in Tumors
无创监测肿瘤中的谷胱甘肽代谢
  • 批准号:
    7760978
  • 财政年份:
    2006
  • 资助金额:
    $ 26.01万
  • 项目类别:
Noninvasive Monitoring Glutathione Metabolism in Tumors
无创监测肿瘤中的谷胱甘肽代谢
  • 批准号:
    7578281
  • 财政年份:
    2006
  • 资助金额:
    $ 26.01万
  • 项目类别:

相似海外基金

Life outside institutions: histories of mental health aftercare 1900 - 1960
机构外的生活:1900 - 1960 年心理健康善后护理的历史
  • 批准号:
    DP240100640
  • 财政年份:
    2024
  • 资助金额:
    $ 26.01万
  • 项目类别:
    Discovery Projects
Development of a program to promote psychological independence support in the aftercare of children's homes
制定一项计划,促进儿童之家善后护理中的心理独立支持
  • 批准号:
    23K01889
  • 财政年份:
    2023
  • 资助金额:
    $ 26.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
  • 批准号:
    10452217
  • 财政年份:
    2022
  • 资助金额:
    $ 26.01万
  • 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
  • 批准号:
    10670838
  • 财政年份:
    2022
  • 资助金额:
    $ 26.01万
  • 项目类别:
Aftercare for young people: A sociological study of resource opportunities
年轻人的善后护理:资源机会的社会学研究
  • 批准号:
    DP200100492
  • 财政年份:
    2020
  • 资助金额:
    $ 26.01万
  • 项目类别:
    Discovery Projects
Creating a National Aftercare Strategy for Survivors of Pediatric Cancer
为小儿癌症幸存者制定国家善后护理策略
  • 批准号:
    407264
  • 财政年份:
    2019
  • 资助金额:
    $ 26.01万
  • 项目类别:
    Operating Grants
Aftercare of green infrastructure: creating algorithm for resolving human-bird conflicts
绿色基础设施的善后工作:创建解决人鸟冲突的算法
  • 批准号:
    18K18240
  • 财政年份:
    2018
  • 资助金额:
    $ 26.01万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Development of an aftercare model for children who have experienced invasive procedures
为经历过侵入性手术的儿童开发善后护理模型
  • 批准号:
    17K12379
  • 财政年份:
    2017
  • 资助金额:
    $ 26.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a Comprehensive Aftercare Program for children's self-reliance support facility
为儿童自力更生支持设施制定综合善后护理计划
  • 批准号:
    17K13937
  • 财政年份:
    2017
  • 资助金额:
    $ 26.01万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Project#2 Extending Treatment Effects Through an Adaptive Aftercare Intervention
项目
  • 批准号:
    8742767
  • 财政年份:
    2014
  • 资助金额:
    $ 26.01万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了